Hao Sheng-Yu, Muhetaer Yaxiaerjiang, Zheng Xin, Long Yu-Liang, Song Jie-Qiong, Zhong Ming
Department of Critical Care Medicine, Zhongshan Hospital Affiliated to Fudan University, Shanghai 200032, China.
Department of Cardiology, Zhongshan Hospital Affiliated to Fudan University, Shanghai 200032, China.
World J Clin Cases. 2025 Apr 16;13(11):98128. doi: 10.12998/wjcc.v13.i11.98128.
Postpartum pulmonary arterial hypertension (PAH) complicated with hereditary hemorrhagic telangiectasia (HHT) is a rare condition. Diagnosing and treating PAH in patients with HHT can be challenging. To the best of our knowledge, no previous reports have investigated the efficacy of pulmonary vasodilators in improving hemodynamics in postpartum patients with this disease.
In this paper, we report a postpartum case of HHT combined with PAH, presenting with worsening dyspnea. Genetic testing revealed that the patient carried a heterozygous variant of activin receptor-like kinase 1. The patient received various treatments, including diuretics, anticoagulants, sildenafil, macitentan, inhalation of nitric oxide, and iloprost. Changes in PaO/FiO, pulmonary artery systolic pressure as assessed by echocardiography, and N-terminus pro-brain natriuretic peptide levels suggested that, except for iloprost inhalation, the other treatments appeared to have limited efficacy.
To our knowledge, this is the first report on efficacy of pulmonary vasodilators in postpartum patients with HHT and PAH.
产后肺动脉高压(PAH)合并遗传性出血性毛细血管扩张症(HHT)是一种罕见疾病。诊断和治疗HHT患者的PAH具有挑战性。据我们所知,此前尚无报告研究肺血管扩张剂对改善该疾病产后患者血流动力学的疗效。
本文报告1例产后HHT合并PAH病例,患者出现进行性加重的呼吸困难。基因检测显示该患者携带激活素受体样激酶1的杂合变异。患者接受了包括利尿剂、抗凝剂、西地那非、马昔腾坦、吸入一氧化氮和伊洛前列素在内的多种治疗。动脉血氧分压/吸入氧分数值(PaO/FiO)、超声心动图评估的肺动脉收缩压以及N末端脑钠肽前体水平的变化表明,除伊洛前列素吸入外,其他治疗似乎疗效有限。
据我们所知,这是关于肺血管扩张剂对产后HHT合并PAH患者疗效的首份报告。